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Toxoplasma gondii is an apicomplexan parasite that infects almost all warm-blooded
animals. Little is known about how the parasite virulence in mice extrapolates to other
relevant hosts. In the current study, in vitro phenotype and in vivo behavior in mice and
sheep of a type II T. gondii isolate (TgShSp1) were compared with the reference type II
T. gondii isolate (TgME49). The results of in vitro assays and the intraperitoneal inoculation
of tachyzoites inmice indicated an enhanced virulence for the laboratory isolate, TgME49,
compared to the recently obtained TgShSp1 isolate. TgShSp1 proliferated at a slower
rate and had delayed lysis plaque formation compared to TgME49, but it formed more
cyst-like structures in vitro. No mortality was observed in adult mice after infection with
1–105 tachyzoites intraperitoneally or with 25–2,000 oocysts orally of TgShSp1. In sheep
orally challenged with oocysts, TgME49 infection resulted in sporadically higher rectal
temperatures and higher parasite load in cotyledons from ewes that gave birth and
brain tissues of the respective lambs, but no differences between these two isolates
were found on fetal/lamb mortality or lesions and number of T. gondii-positive lambs.
The congenital infection after challenge at mid-pregnancy with TgShSp1, measured as
offspring mortality and vertical transmission, was different depending on the challenged
host. In mice, mortality in 50% of the pups was observed when a dam was challenged
with a high oocyst dose (500 TgShSp1 oocysts), whereas in sheep infected with the
same dose of oocysts, mortality occurred in all fetuses. Likewise, mortality of 9 and 27%
of the pups was observed in mice after infection with 100 and 25 TgShSp1 oocysts,
respectively, while in sheep, infection with 50 and 10 TgShSp1 oocysts triggeredmortality
in 68 and 66% of the fetuses/lambs. Differences in vertical transmission in the surviving
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offspring were only found with the lower oocyst doses (100% after infection with 10
TgShSp1 oocysts in sheep and only 37% in mice after infection with 25 TgShSp1
oocysts). In conclusion, virulence in mice of T. gondii type II isolates may not be a good
indicator to predict the outcome of infection in pregnant sheep.
Keywords: Toxoplasma gondii, type II, virulence, phenotypic traits, mice, sheep, congenital toxoplasmosis
INTRODUCTION
Toxoplasma gondii is an apicomplexan parasite capable of
infecting almost all warm-blooded animals and causing
potentially fatal disease in humans and some relevant domestic
species, such as small ruminants (Dubey, 2010). Toxoplasma
gondii may be transmitted horizontally by oral ingestion of
infectious oocysts from the environment and tissue cysts
contained in raw and undercooked meat or vertically by
transplacental transmission of tachyzoites (Tenter et al., 2000).
Toxoplasma gondii diverges in three main clonal lineages, I, II,
and III, with marked differences in mouse virulence (Howe and
Sibley, 1995) although atypical strains have been also described
(Su et al., 2006). Type I isolates are highly virulent in mice,
whereas types II and III show a dose-dependent mortality (Saeij
et al., 2006). Laboratory isolates from types I, II, and III are used
in T. gondii research and have been maintained in successive
passages in cell culture andmice. Enhanced virulence throughout
successive passages in cell culture and mice for T. gondii type I
isolates (e.g., RH isolate) has been widely reported (Villard et al.,
1997; Mavin et al., 2004; Khan et al., 2009), but little is known
about the influence of continuous passages in type II isolates.
Likewise, there is little information on how T. gondii virulence in
mice compares to virulence in other species, particularly in those
experiencing clinical toxoplasmosis, such as sheep and humans.
Transmission of T. gondii from dams to offspring during
pregnancy (congenital toxoplasmosis) is one of the consequences
of infection (Innes et al., 2009; McAuley, 2014). Many animal
experimental models have been developed; among them, mouse
models are the most frequently used due to similarities in
placental histology between rodents and humans (Vargas-
Villavicencio et al., 2016). However, the structure of the
placenta, reproductive physiology and immune responses greatly
differ between rodents and ruminants, which clearly could
influence the passing of T. gondii through the maternofetal
interface and the modulation of the host immune responses
during pregnancy (Entrican, 2002). In sheep, T. gondii is
one of the main abortifacient agents (Dubey, 2009). Type II
T. gondii isolates are the most prevalent in all of the hosts in
Europe, including sheep (Chessa et al., 2014). In most of the
experimental studies in pregnant sheep, type II isolates M1,
M3, and M4 have been used (Dubey, 2009; Castaño et al.,
2014), but the virulence in mice of these isolates was never
assessed.
The aim of this study was to compare the phenotype in vitro
and the virulence in mice of a newly obtained T. gondii type II
isolate (TgShSp1) with that of the laboratory type II reference
isolate (TgME49) and to compare congenital infection in mice
and in sheep.
MATERIALS AND METHODS
Ethics Statement
Animal procedures for the T. gondii isolation by a mouse
bioassay of field samples from sheep abortions (PROEX 274/16),
for evaluation of virulence by intraperitoneal inoculation of
tachyzoites in non-pregnant mice (PROEX 274/16) and for
T. gondii infection of mice and cats (PROEX 166/14) for
oocyst production were approved by the Animal Welfare
Committee of the Community of Madrid, Spain, following
proceedings described in Spanish and EU legislation (Law
32/2007, R.D. 53/2013, and Council Directive 2010/63/EU).
Animal procedures to characterize TgShSp1 oocysts in pregnant
mice were approved by the Animal Welfare Committee of
the Canton of Bern (approval No. BE 101/17). All sheep
handling practices were approved by the local government and
followed the recommendations of the Directive 2010/63/EU of
the European Parliament, the Council on the protection of
animals used for scientific purposes, and the IGM-CSIC Animal
Experimentation Committee (protocol number 416-2016). All
animals used in this study were handled in strict accordance with
good clinical practices, and all efforts were made to minimize
suffering.
T. gondii Isolates, Isolation of the TgShSp1,
and Genotyping
The T. gondii type II ovine isolate TgME49 (genotype #1) isolated
in 1958 from sheep muscle (Lunde and Jacobs, 1983) was kindly
donated by Dr. J. C. Boothroyd and had an unknown passage
number, but it had been routinely maintained in cell culture and
mice. The T. gondii type II (genotype #3) isolate (TgShSp1) was
obtained from a T. gondii ovine abortion outbreak in September
and October 2015 in a Spanish sheep flock (Assaf breed) in the
province of Palencia (northwest Spain), which suffered abortion
in 30 out of 239 pregnant sheep (12.5%).
TgShSp1 was isolated by passage in mice from a brain of an
ovine aborted fetus, in which T. gondii infection was confirmed
by PCRwithin 24 h after collection as described (Regidor-Cerrillo
et al., 2008). Briefly, fetal brain (6 g) was homogenized in 6mL
of PBS containing 2% antibiotic-antimycotic solution (Gibco,
Thermo Fisher Scientific, Waltham, MA, USA), filtered in sterile
gauze, and centrifuged at 1,350 g for 15min. The supernatant was
discarded, and the sediment was suspended in 1,400 µL of PBS
with antibiotic-antimycotic solution, and 400 µL was inoculated
subcutaneously into one 8-weeks-old female CD1mouse that was
followed for clinical signs. At day 40 pi, asymptomatic mouse
were euthanized, and the brain collected and tested by PCR (see
below). The PCR-positivemouse brain was homogenized in 1,000
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µL of PBS with antibiotics by passing through a descending
series of needles (20–25G) and immediately subcutaneously
inoculated into two other CD1 mice (500 µL to each mice).
At 11 dpi, mice were euthanized, and peritoneal flushes were
used for isolation in MARC-145 cell culture (Regidor-Cerrillo
et al., 2008) and checked for the presence of parasite by PCR.
Toxoplasma gondii tachyzoites were observed in cell cultures at
4 days after inoculation of peritoneal flushes on MARC-145 cells
and maintained by successive passages until cryopreservation.
The T. gondii isolate obtained was genotyped by polymerase
chain reaction–restriction fragment length polymorphism (PCR-
RFLP) using 12 molecular markers (SAG1, 3′-SAG2, 5′-SAG2,
Alt.SAG2, SAG3, BTUB, GRA6, c22-8, c29-2, L358, PK1, and
Apico) as previously described (Su et al., 2006). The digested PCR
products were visualized by 2.5% agarose gel electrophoresis,
stained with Gel Red R© Nucleic Acid Gel Stain (Biotium R©,
Fremont, California, USA), observed under UV light, assigned
to a T. gondii type and classified according to genotypes present
in ToxoDB (http://toxodb.org/toxo/).
In vitro Assays
MARC-145, Vero and Human Foreskin Fibroblasts (HFF)
cell lines were used for studying the tachyzoite-to-bradyzoite
conversion and proliferation of T. gondii isolates in vitro. Cells
were routinely maintained in DMEM (Gibco, Thermo Fisher
Scientific, Waltham, MA, USA) with phenol red supplemented
with 10% heat-inactivated, sterile, filtered fetal calf serum
(FCS) (Gibco, Thermo Fisher Scientific, Waltham, MA, USA),
2mM glutamine (Lonza Group, Basel, Switzerland) and a
mixture of penicillin (100 U/ml), streptomycin (100µg/ml), and
amphotericin B (Lonza Group, Basel, Switzerland) at 37◦C in a
humidified atmosphere of 5% CO2. TgME49 and TgShSp1 were
maintained by serial passages in MARC-145 and Vero cells in the
same culture medium with 2% FCS. Tachyzoites used for in vitro
assays were harvested 3 days pi (TgME49) or 5 days pi (TgShSp1,
passage 10), when the majority of parasites were still intracellular
and purified by a PD-10 column (GE Healthcare, Little Chalfont,
United Kingdom), as described (Regidor-Cerrillo et al., 2011).
Tachyzoite viability was confirmed by trypan blue exclusion, and
numbers were determined by counting in a Neubauer chamber.
All assays were carried out in triplicate, including at least three
replicates in each assay.
Evaluation of the Tachyzoite-to-Bradyzoite
Differentiation in vitro Through Cyst Wall-Specific
DBL Staining
Purified T. gondii parasites of the TgME49 or TgShSp1 isolate
(2 × 103 tachyzoites) were added to MARC-145 monolayers
grown to confluence in 24-well plates. At 24 h, culture medium
was replaced by DMEM with alkaline pH (8–8.2), and plates
were incubated at 37◦C without CO2 supplementation for 3–4
days (Skariah et al., 2010) to evaluate induced differentiation.
Duplicate plates were maintained for 3 days under regular
conditions to evaluate spontaneous differentiation (pH 7.2–
7.4 and 5% CO2). Tachyzoite-to-bradyzoite conversion was
evaluated at 72–96 h by double immunofluorescence staining
in cell monolayers fixed with paraformaldehyde 3% and
glutaraldehyde 0.05% and permeabilized with Triton X-100
0.25%, using a polyclonal mouse-anti T. gondii antiserum at
a dilution of 1:100 as primary antibody, Alexa Fluor R© 594
Goat Anti-Mouse IgG (H + L) (Life technologies, Carlsbad,
CA, USA) at a dilution of 1:1,000 as secondary antibody for
parasite staining, and the Dolichos biflorus lectin (DBL) (Vector
Labs, Burlingame, United States) at a dilution of 1:50 for cyst
wall staining. Cell nuclei were stained with DAPI. Finally,
the total numbers of DBL-positive cysts and DBL-negative
structures compatible with parasite structures, including lysis
plaques, were counted using an inverted fluorescence microscope
(Nikon Eclipse TE200) at 200x magnification. The percentage of
conversion for each well was determined.
In vitro Intracellular Proliferation Assays
Toxoplasma gondii proliferation was evaluated in Vero cells by a
plaque assay and in HFF determining the tachyzoite yield at 48 h
pi. For this assay, Vero cultures grown to confluence in 24-well
plates were infected with 5 × 104 purified tachyzoites of either
TgME49 or TgShSp1 and further maintained at 37◦C and 5%
CO2 for 4 days and stained with 0.2% crystal violet (Alfa Aesar,
Haverhill, Massachusetts, United States) solution in 2% ethanol
(Ufermann et al., 2017). Images were captured using a SMZ1000
binocular loupe (Nikon R©, Tokyo, Japan).
Tachyzoite yield in HFF was determined by quantifying the
number of tachyzoites at 48 h pi (TY48h) by real-time PCR
(qPCR). HFF cultures grown to confluence in 24-well plates were
infected with 105 purified T. gondii tachyzoites and maintained
for 48 h at 37◦C in 5% CO2 as previously described (Regidor-
Cerrillo et al., 2011). Then, the medium was removed, and cells
were recovered in 150 µL lysis buffer and 10 µL proteinase
K (Macherey-Nagel, Düren, Germany) for DNA extraction and
quantification of parasite genomic DNA by qPCR.
In vivo Experimental Infections
Virulence Assessment in Non-pregnant Mice
Intraperitoneally Inoculated With TgShSp1 and
TgME49 Tachyzoites
TgShSp1 and TgME49 virulence was determined in mice
following recommendations for standardization described
by Saraf et al. (2017). For the in vivo challenge, tachyzoites
of TgShSp1 (passaged 10 times in cell culture) and TgME49
(unknown passage number) were recovered from Vero cultures
when they were still largely intracellular (>80% of undisrupted
parasitophorous vacuoles) (Regidor-Cerrillo et al., 2010),
repeatedly passed through a 27-gauge needle at 4◦C and filtered
through a 5-µm polycarbonate filter (IpPORE R©, IT4IP, Louvain-
la-Neuve, Belgium) (Saraf et al., 2017). The tachyzoite viability
was determined by Trypan blue exclusion and counted in a
Neubauer chamber. Tachyzoite 10-fold serial dilutions were
performed starting from 105 to 1 tachyzoite(s) suspended in 200
µL of PBS, and each dilution was inoculated intraperitoneally
into five 8-weeks-old female CD1 mice (Janvier-Labs, Laval,
France) within 30min of harvesting the parasites from cell
culture. Five control female mice were inoculated with PBS.
Mice were observed daily and clinical signs (morbidity) were
scored according to the description made by Arranz-Solis et al.
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(2015a). Briefly, scores were classified as 0 (no alterations),
1 (ruﬄed coat), 2 (rounded back), 3 (noticeable loss of body
condition/severe weight loss), or 4 (nervous signs such as activity
decrease, hind limb paralysis, walking in circles, or head tilt).
As a humane endpoint, mice exhibiting evident loss of body
condition (score of 3) or nervous signs (score of 4) were culled to
limit unnecessary suffering. Mice with clinical scores of 0, 1, and
2 were euthanized at 6 weeks p.i. Samples of blood were collected
from mice for serology by IFAT and brain and lung for parasite
detection by PCR.
Generation, Purification, and Sporulation of T. gondii
Oocysts
Oocysts of the TgShSp1 isolate were obtained through oral
infection of cats as previously described (Müller et al., 2017).
Briefly, ten 8-weeks-old female CD1 mice (Janvier-Labs, Laval,
France) were inoculated intraperitoneally with 105 tachyzoites
of TgShSp1 (passage 10). At 2 months post-inoculation, mice
were euthanized, and the brains were collected. Two 12-weeks-
old kittens free of T. gondii and other relevant feline pathogens
(Isoquimen S.L., Barcelona, Spain) were fed a pool of 5 brains
each. Feces were collected from kittens daily and examined to
detect shedding of T. gondii oocysts. Unsporulated oocysts were
harvested from feces and sporulated by resuspending in 2%
H2SO4 for 4 days at room temperature. Sporulated oocysts were
kept at 4◦C until used. The same batch of sporulated oocysts
of the TgME49 and TgShSp1 was used in mouse and sheep
infections. Sporulated oocysts of TgME49 originated from the
same batch as described earlier (Müller et al., 2017).
Assessment of TgShSp1 Oocyst Infection in
Pregnant Mice
TgShSp1 was evaluated in pregnant mice out similarly as
previously described for TgME49 (Müller et al., 2017). CD1
females (50 mice) and males (25 mice) were purchased from
Charles River Laboratories (Sulzberg, Germany) at the age
of 8 weeks and were maintained in a common room under
conventional day/night cycle housing conditions. Females at
9 weeks of age were synchronized with respect to estrus and
were distributed into cages, where two females and one male
were housed together for 3 days (during which 3 females died).
Subsequently, the female mice were orally infected by gavage
with high doses of oocysts: 2,000 oocysts (group A, n = 9) and
500 oocysts (group B, n = 9), an intermediate dose of oocysts:
100 oocysts (group C, n = 10) and a low dose of oocysts: 25
oocysts (group D, n= 10) suspended in 100µL of carboxymethyl
cellulose solution (0.5% in water) at day 7 post-mating. The
control group (group E, n = 9) received carboxymethyl cellulose
solution alone. Pregnancy was confirmed 2 weeks post-mating
by weighing, and pregnant mice were then allocated into single
cages to give birth on days 19–22 and to rear their pups for
an additional 4 weeks. During this time, those females that
had remained non-pregnant were maintained in cages of three
to five mice. Dams and their offspring were evaluated daily
from birth to day 28 post-partum (pp). Despite the numerous
parameters evaluated, pup mortality (number of pups born dead
or euthanized due to severe clinical signs as described above for
intraperitoneal inoculation) and vertical transmission (surviving
pups being PCR-positive in the brain) were the most relevant
assessments. Data on pregnancy rate (percentage of female mice
that became pregnant), litter size (number of delivered pups per
dam), and clinical signs (morbidity) of dams and non-pregnant
mice were recorded during this time as described above for
intraperitoneal inoculation. Neonates were weighed every second
day from day 14 pp until the end of the experiment (day 28 pp)
to evaluate morbidity in the offspring. Day 14 pp was chosen as a
starting point for weight monitoring to avoid excessive handling
of the pups during the first 2 weeks after birth, which can result
in rejection by the dams. Dams, non-pregnant mice and pups
were euthanized in a CO2 chamber at 28 days pp. Blood from
dams and non-pregnant mice was recovered by cardiac puncture,
and sera were obtained to test humoral immune responses.
Brains and lungs were removed from dams and non-pregnant
mice and stored at −20◦C until determination of parasite load.
The heads of pups that survived were collected and stored at
−20◦C. Subsequently, the frozen heads were cleaved and brains
were removed. The frozen brains from pups were immediately
processed for DNA purification and then parasite quantification.
Whenever possible, dead pups succumbing to the infection early
after birth were removed, their heads sampled and their brains
analyzed.
Assessment of TgShSp1 and TgME49 Oocyst
Infections in Pregnant Sheep
Fifty-four pure Rasa Aragonesa breed female ewes aged 12
months were selected from a commercial flock. All animals
were seronegative for T. gondii, N. caninum, border disease
virus (BDV), Schmallenberg virus (SBV), Coxiella burnetii,
and Chlamydia abortus as determined by enzyme-linked
immunosorbent assay (ELISA). They were estrus-synchronized
and mated with pure-bred Rasa Aragonesa tups for 2 days, after
which the rams were separated from the ewes. Pregnancy and
fetal viability were confirmed by ultrasound scanning (US) on
day 40 post-mating. Pregnant ewes (n = 37) were randomly
distributed into seven experimental groups and housed at the
Instituto de Ganadería deMontaña (CSIC-Universidad de León),
León, Spain.
Thirty-three pregnant ewes were orally dosed on day 90 of
pregnancy with a high dose of oocysts (500 sporulated oocysts) of
TgShSp1 (group 500A, G500A, n = 6) or TgME49 (group 500B,
G500B, n = 5), an intermediate dose of oocysts (50 oocysts) of
TgShSp1 (group 50A, G50A, n = 6) or TgME49 (group 50B,
G50B, n = 5) or a low dose of oocysts (10 oocysts) of TgShSp1
(group 10A, G10A, n= 6) or TgME49 (group 10B, G10B, n= 5).
The four remaining sheep were used as negative controls of
infection (uninfected) and received 50mL of PBS on day 90 of
pregnancy.
Pregnant ewes were observed daily throughout the
experimental period. Rectal temperatures were recorded
daily from day 0 until 14 days pi and then weekly to evaluate
morbidity. The physiological range for rectal temperatures
in sheep was obtained from Diffay et al. (2002), and rectal
temperatures above 40◦C were considered hyperthermic. Fetal
viability was assessed by US monitoring of fetal heartbeat and
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movements twice a week after infection. When fetal death
occurred, or immediately after parturition, dams and lambs
were first sedated with xylazine (Rompun, Bayer, Mannheim,
Germany) and then euthanized by an intravenous overdose
of embutramide and mebezonium iodide (T61, Intervet,
Salamanca, Spain). Animals from the uninfected group were
examined by US every 2 weeks.
According to the survival in fetuses/lambs, sheep were
classified into three categories: (a) suffering early abortions
(i.e., between 8 and 11 dpi); (b) suffering late abortions,
which occurred from 12 to 50 dpi; and (c) sheep delivering
stillbirths, mummified fetuses or live lambs from 51 dpi. After
birth, lambs were clinically inspected and then sedated and
euthanized. Lambs showing weakness in relation to all live lambs
were used to calculate morbidity in the offspring. In spite of
the numerous parameters evaluated, fetal/lamb mortality and
vertical transmission in live lambs (seropositivity and parasite
detection in brain or lung) were the most relevant assessments.
Blood samples to evaluate humoral immune responses were
collected prior to infection, at 3, 5, 7, and 10 days pi and then
weekly by jugular blood draw. Precolostral serum was collected
from lambs immediately after delivery from dams. To prevent
any transmission of colostral antibodies from dams, udders were
covered with a piece of cloth 1 week before the expected date of
delivery as a preventive measure, and lambs were separated from
theirmothers immediately after birth. Serum samples were stored
at−80◦C until analysis.
During necropsy, six randomly selected placentomes or
cotyledons from aborted dams and dams that gave birth,
respectively, were recovered from each placenta, transversally
cut into 2–3 mm-thick slices, and fixed in 10% formalin for
histopathological examination, whereas the remaining tissues
from these placentomes/cotyledons were stored at −80◦C for
further DNA extraction and PCR analyses. Samples from fetal
tissues, including brain and lungs, were stored at−80◦C for DNA
extraction or were fixed in 10% formalin for histopathology.
Thoracic and abdominal fluids were also collected from fetuses
and stillborn lambs from which precolostral sera could not be
obtained, and maintained at−80◦C for serology.
Serological Analyses: IFAT and ELISA
The serum samples from mice used for isolation
and determination of virulence were analyzed by the
immunofluorescence antibody test (IFAT) for the detection
of anti-T. gondii IgG as previously described (Alvarez-Garcia
et al., 2003), using an anti-mouse IgG conjugated to FITC
(Sigma-Aldrich, Madrid, Spain) diluted 1:64 in Evans Blue
(Sigma-Aldrich). We used the cut-off of 1:25. Serum titers
for T. gondii in oocyst-infected mice were assessed by ELISA
as previously described for Neospora caninum-infected mice
(Debache et al., 2008, 2009), except that soluble antigen extract
from T. gondii tachyzoites was used (Alaeddine et al., 2005).
Toxoplasma gondii-specific IgG antibody levels in sheep
were measured using an in-house indirect ELISA similarly
as previously described (Castaño et al., 2014). The indirect
fluorescent antibody test (IFAT) was used to detect specific IgG
anti-Toxoplasma antibodies in fetal fluids and precolostral sera,
adapting the technique previously described for IFAT analysis in
N. caninum-infected animals (Alvarez-Garcia et al., 2003), using
an anti-sheep IgG (Sigma-Aldrich) diluted 1:200 in Evans blue
(Sigma-Aldrich). Fetal fluids and precolostral sera were diluted at
2-fold serial dilutions in PBS starting at 1:8 (for fetal fluids) and
1:50 (for precolostral sera) up to the endpoint titer. Continuous
tachyzoite membrane fluorescence at a titer ≥8 for fetal fluids or
≥50 for precolostral sera was considered a positive reaction.
DNA Extraction and PCR for Parasite
Detection and Quantification in Tissues
Genomic DNA from in vitro samples was extracted from these
samples using the NucleoSpin R© DNA RapidLyse Kit (Macherey-
Nagel, Düren, Germany) according to the manufacturer’s
instructions. DNA concentrations were adjusted to 20 ng/µL and
quantified using qPCR with primer pairs for the 529-bp repeat
element for T. gondii for parasite quantification and primer pairs
for the 28S rRNA gene for quantify cell DNA under conditions
previously described (Collantes-Fernández et al., 2002; Castaño
et al., 2016, respectively).
Genomic DNA was extracted from mice that were used
for isolation and determination of virulence out using the
commercial Maxwell R© 16 Mouse Tail DNA Purification Kit.
The T. gondii DNA detection was carried out by an ITS-1 PCR
adapted to a single tube as previously described (Castaño et al.,
2014). DNA extraction and qPCR analysis from oocyst-infected
mice were performed as previously described (Müller et al.,
2017).
In sheep, genomic DNA was extracted from three 50–100mg
samples taken from each location: six placentomes in aborted
dams or six cotyledons in dams that gave birth, as well as fetal
brain and lung, using the commercial Maxwell R© 16 Mouse Tail
DNA Purification Kit. T. gondii DNA detection was carried out
by an ITS-1 PCR as described above (Castaño et al., 2014). DNA
that tested positive by nested-PCR was adjusted to 20 ng/µL and
quantified using qPCR as previously described (Castaño et al.,
2014). Parasite number in tissue samples (parasite burden) was
expressed as parasite number/mg ovine tissue. Standard curves
for T. gondii and sheep DNA showed an average slope of −3.44
and−3.30, respectively, and anR2 > 0.99. Parasite-negative DNA
samples were included in each round of DNA extraction and PCR
as negative controls.
Histological Processing
After fixation for 5 days, placental and fetal sheep tissues were
cut coronally, embedded in paraffin wax and processed by
standard procedures for hematoxylin and eosin (HE) staining.
Conventional histological evaluation was carried out on all
sections. To quantify the lesions in the brain of stillborn lambs
and live lambs, the number and size of glial foci, as well as
the total area of lesion in the examined tissue, were calculated
through a computer-assisted morphometric analysis on HE-
stained sections following the procedure described previously
(Arranz-Solis et al., 2015b).
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Statistical Analysis
The growth rate and percentage of DBL-positive cysts in vitro of
TgME49 and TgShSp1 were compared using the Mann–Whitney
test. In pregnant mice, differences in seroconversion, pregnancy
rates, litter size, pup mortality, and parasite presence in tissues
were analyzed by the χ2-test or Fisher’s exact F-test. One-way
ANOVA followed by Tukey’s multiple comparisons test were
employed to compare body weights. Parasite burdens and anti-
T. gondii antibody levels were analyzed using the non-parametric
Kruskal–Wallis test followed by Dunn’s test for comparisons
between groups, as well as the Mann–Whitney test for pairwise
comparisons.
In pregnant sheep, the number of fetuses/lambs suffering
mortality and the number of weak lambs (morbidity)
were compared using the χ2-test or Fisher’s exact F-test.
Rectal temperatures and humoral immune responses were
analyzed using one-way ANOVA followed by Tukey’s multiple
comparisons test until 14 days pi or until the end of the
experiment. Differences in frequency of PCR detection of
parasite DNA and in the percentage of cases showing lesions were
evaluated using the χ2-test or Fisher’s exact F-test. Differences in
parasite burdens and histological measurements of lesions were
analyzed using the non-parametric Kruskal–Wallis test followed
by Dunn’s test for comparisons between groups, as well as the
Mann–Whitney test for pairwise comparisons.
Differences between mice and sheep in the number of
fetuses/pups/lambs that died in relation to the total number
of fetuses/pups/lambs or in the number of surviving offspring
infected with T. gondii in relation to all live offspring were
assessed using the χ2-test or Fisher’s exact F-test. Likewise, a
categorization of the parameters to evaluate congenital infection
was done, into high (>67%), medium (66–34%), low (<33%), or
none (0%) of the fetuses/pups/lambs with clinical signs, offspring
mortality or vertical transmission. Statistical significance for all
analyses was established at P < 0.05. All statistical analyses were
performed using GraphPad Prism 6.01 software (San Diego, CA,
USA).
RESULTS
Isolation of the T. gondii Isolate TgShSp1
From a Sheep Flock in Spain
On day 40 post-inoculation, one mouse inoculated with the brain
homogenate of the sheep abortion was T. gondii PCR-positive
in the brain. The peritoneal fluid of one of the other two mice
inoculated with the positive mouse brain was PCR-positive on
day 11 pi. Four days after inoculating the PCR-positive peritoneal
flush into cell culture, the isolation of TgShSp1 was confirmed.
Genotyping classified TgShSp1 as genotype #3 (a type II variant,
type II for nine alleles/type I for Apico) (ToxoDB).
TgShSp1 and TgME49 Differ in Behavior
in vitro
TgShSp1 Exhibits a High Capacity to Form Cysts
in vitro
At difference in TgME49 free-floating cyst-like structures was
often identified by light microscopy in the TgShSp1 infected
cultures at 3 days p.i. in successive passages. TgShSp1 cultured
under regular conditions (at a neutral pH) demonstrated
spontaneous conversion to bradyzoite with a statistically higher
number of DBL-positive cysts (14%) compared to TgME49
(2%) (P < 0.0001). Additionally, after induction of bradyzoite
development (at a basic pH), TgShSp1 formed a higher number
of DBL-positive cysts (55%) compared to TgME49 (33%)
(P < 0.0001) (Figure 1A).
TgME49 Shows a Higher Growth Rate in vitro Than
TgShSp1
Evaluation of parasite growth in Vero cells by a lysis plaque assay
showed that TgME49 produced large clear zones due to host cell
lysis, while during the same period, TgShSp1 showed essentially
an intact monolayer cell (Figure 1B). Determination of the TY48h
in HFF was also assessed to confirm differences in parasite
growth. The TY48h values for TgME49 were significantly higher
compared to those from TgShSp1 (P < 0.0001) (Figure 1C).
TgShSp1 and TgME49 Differ Greatly in
Virulence in Mice
A summary of clinical signs, serology and parasite detection in
mice is shown in Table S1. Most of the mice inoculated with
doses from 105 to 102 tachyzoites of TgShSp1 only exhibited a
ruﬄed coat between days 4 and 13 pi, but they did not have to
be euthanized due to severe clinical signs (Figure 2A; Table S1).
In contrast, upon infection with TgME49, several mice had to
be euthanized due to clinical scores (Figure 2B). The surviving
mice infected with doses from 105 to 10 tachyzoites of TgME49
exhibited clinical signs (rounded back) between days 8 and 14
pi (Table S1). The LD50 for TgME49 was approximately 103
tachyzoites vs. >105 tachyzoites for TgShSp1.
All mice inoculated with doses from 105 to 10 tachyzoites of
TgShSp1 were seropositive at 6 weeks pi, with IFAT titers ranging
from 1:400 to 1:3,200. Concerning mice infected with TgME49,
mice euthanized prior to day 24 pi were seronegative, while one
mouse infected with 103 tachyzoites euthanized on day 33 pi had
an IFAT titer of 1:25. Survivors infected with doses from 105 to
10 tachyzoites of TgME49 were seropositive at 6 weeks pi, with
IFAT titers ranging from 1:50 to 1:800 (Table S1).
All mice infected with doses from 105 to 10 tachyzoites
of TgME49 and TgShSp1 were PCR-positive in the brain,
confirming T. gondii infection. Likewise, almost all lung samples
from mice infected with doses from 105 to 10 tachyzoites of both
isolates were PCR-positive, except lung samples from surviving
mice infected with 10 tachyzoites of TgME49. Mice infected with
1 tachyzoite did not show clinical signs, they were seronegative,
and all tissue samples were PCR-negative, identical to uninfected
mice (Table S1).
TgShSp1 Shows Low Virulence in Mice
Infected With Oocysts but Is Efficiently
Transmitted to Offspring
Evaluation of TgShSp1 Infection in Dams
Clinical signs in infected dams were generally mild. Therefore,
none of the dams had to be euthanized due to severe clinical
signs. At 12 days pi, one out of five dams infected with 2000
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FIGURE 1 | Tachyzoite-to-bradyzoite differentiation, plaque formation and
tachyzoite yield in vitro of TgME49 and TgShSp1 isolates. (A) In vitro
tachyzoite-to-bradyzoite differentiation at neutral and alkaline pH. Percentage
of events being DBL-positive cysts at pH 7 and pH 8 are represented. The rest
of non-represented events were found to be DBL-negative structures and lysis
plaques. ****Marks the higher spontaneous and induced differentiation into
bradyzoites with the TgShSp1 isolate. (B) Plaque formation with TgShSp1 (I)
and TgME49 (II) isolates. Plaques are visible as clear zones on a crystal
violet-stained Vero monolayer background. (C) A column-plot graph
representing the tachyzoite yield (TY48h ) of TgME49 and TgShSp1. Values of
replicates from experiments performed in triplicate for each isolate. Error bars
indicate the SD. ****Marks the significantly higher TY48h values for TgME49
compared to TgShSp1.
oocysts (group A) exhibited ruﬄed coat (1), and one out of six
dams infected with 500 oocysts (group B) displayed rounded
back (2). No clinical signs were observed in dams infected with
100, 25, or 0 oocysts (groups C, D, and E). Pregnancy rates
ranged from 55 to 66%, with no significant differences between
them. Similarly, no differences between the groups were found in
litter size (11.8–14.4 delivered pups), suggesting that pregnancy
FIGURE 2 | Survival curve of CD1 mice after infection with T. gondii
tachyzoites of TgShSp1 isolate (A) or TgME49 isolate (B). Five mice per group
were infected i.p. with 105, 104, 103, 102, 10, or 1 tachyzoite of the TgShSp1
isolate or the TgME49 isolate. Survival was monitored for 42 days. Each point
represents the percentage of surviving animals at that day, and downward
steps correspond to euthanasia due to severe clinical signs.
was not noticeably altered by infection with TgShSp1 oocysts
(Table 1).
All infected dams with 2,000, 500, and 100 oocysts (groups
A, B, and C) developed Toxoplasma-specific humoral immune
responses at day 28 pp. However, although only seroconversion
in half of the dams was observed in the group infected with
25 oocysts (group D), there were no statistically significant
differences in the number of dams showing seroconversion
between infected groups (Table 1). Anti-T. gondii IgG levels were
significantly increased in groups infected with 2,000 (P < 0.05),
500 (P < 0.01), and 100 oocysts (P < 0.01) in comparison to
the unchallenged group in which all dams were seronegative
(Figure S1A). Toxoplasma gondii DNA was detected in the brain
of all dams from infected groups, with the exception of three
dams in the group infected with 25 oocysts (group D) (Table 1).
Quantitative evaluation of parasite burdens in brain showed no
significant differences between infected groups (Figure S2A). In
the lungs, parasite DNA was detected in the 50–83% of the dams
from oocyst-infected groups, without significant differences in
parasite detection or parasite load between them (Figure S3A;
Table 1).
Evaluation of TgShSp1 Infection in Offspring Mice
Most pups were born dead (82/93; 88%), although a few pups had
to be euthanized due to severe clinical signs between day 2 and
day 21 pp (11/93; 12%). Half of the pups in the group infected
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with 2,000 oocysts (group A) and with 500 oocysts (group B)
were born dead or had to be euthanized due to severe clinical
signs and had significantly higher pup mortality compared to the
uninfected group (P < 0.05) (Table 1). In groups infected with
100 oocysts (group C) and 25 oocysts (group D), respectively,
9 and 27% of pups were born dead or had to be euthanized
due to severe clinical signs. Only one of seventy-two pups was
born dead in the uninfected group (group E) (Table 1). Starting
from day 14 pp, offspring of the uninfected group (group E)
showed significantly higher body weight than groups infected
with 500 (P < 0.0001) and 100 oocysts (P < 0.001), and the
same was true of those infected with 2,000 oocysts (group A)
from day 22 pp (P < 0.001). However, no decreased body
weight was noted in pups infected with 25 oocysts (group D)
(Figure 3A).
Vertical transmission was detected upon PCR analyses in
all brains (100%) of surviving pups from groups infected with
2,000, 500, and 100 oocysts (groups A, B, and C). However,
parasite was only detected in 37% of the brains from pups
infected with 25 oocysts (group D), with significantly lower
parasite detection compared to groups infected with 2,000, 500,
and 100 oocysts (P < 0.0001) (Table 1). Pups infected with 25
oocysts (group D) and with 100 oocysts showed lower parasite
burden compared to those infected with 2,000 and 500 oocysts
(groups A and B) (P < 0.0001) (Figure 3B). No T. gondii DNA
could be detected in the brain of pups that had died on day 0
or 1 pp.
Evaluation of TgShSp1 Oocyst Infection in
Non-pregnant Mice
Similarly, to pregnant mice, clinical signs in non-pregnant mice
infected with oocysts were generally mild. Therefore, none of
the non-pregnant mice had to be euthanized due to severe
clinical signs. Only ruﬄed coat was observed in all mice
infected with 2,000 oocysts (group A), in one out of three
mice in the group infected with 500 oocysts (group B) and
in one out of four non-pregnant mice in the group infected
with 100 oocysts (group C). All infected non-pregnant mice
infected with 2,000, 500, and 100 oocysts (groups A, B, and
C) developed Toxoplasma-specific humoral immune responses
at day 28 p.p. that were significantly increased in comparison
to the unchallenged group, with basal IgG levels (P < 0.05)
(Figure S1B). In the group infected with 25 oocysts (group
D), only three of the four non-pregnant mice seroconverted
(Table 1). Further analyses of antibody responses of pregnant
and non-pregnant mice in each group did not reveal any
significant differences. Toxoplasma gondii DNA was detected in
the brains of all non-pregnant mice from infected groups, with
the exception of one mouse infected with 25 oocysts (group
D) (Table 1). In the lungs, parasite DNA was only detected
in three out of four samples from mice infected with 100
oocysts (group C). Quantitative evaluation showed no significant
differences in brain and lung parasite loads in non-pregnant mice
(Figures S2B, S3B). The comparison of parasite load in brain
and lungs in pregnant mice vs. non-pregnant mice revealed no
significant differences.
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FIGURE 3 | Effect of oral administration of TgShSp1 oocysts in the mouse
pups. (A) Body weight progression of neonates born from dams infected on
day 7 of pregnancy with 2,000 (group A), 500 (group B), 100 (group C), or 25
(group D) TgShSp1 oocysts and the uninfected group (group E). Each point
represents the average body weight of all animals per group. (B) Dot-plot
graph of T. gondii load in brain from surviving pups. Each dot represents
individual values of parasite burden (number of parasites per µg of DNA), and
medians are represented as horizontal lines. ****P < 0.0001.
TgShSp1 and TgME49 Oocyst Infection
Cause Similar Fetal/Lamb Mortality and
Vertical Transmission in Pregnant Sheep
Clinical Observations
No mortality was found in any sheep during the experiment.
All ewes showed fever after infection. Significant increases in
body temperature were found for 3–4 days after day 4 p.i.
in all infected groups. From day 14 pi until the end of the
experiment, no changes were detected in the infected groups.
Likewise, compared to groups infected with 500 oocysts, 1 day
of delay in the increase of rectal temperature (from day 5 to 6 pi)
was found in groups infected with 50 and 10 oocysts (Figure 4).
Differences in temperature increase between groups receiving
the same dose of oocysts of the different T. gondii isolates were
generally not found. As an exception, lower rectal temperatures
were only found on day 8 pi in groups infected with 500 and
10 oocysts of TgShSp1 compared to groups receiving the same
FIGURE 4 | Rectal temperatures of ewes infected with TgShSp1 oocysts and
the uninfected ones (A) and ewes infected with TgME49 oocysts and the
uninfected ones (B) From day 7 pi onwards, some ewes aborted and were
euthanized, and their data are not available. Each point represents the mean +
S.D. at the different sampling times for each group.
doses of TgME49 oocysts (G500A vs. G10A and G500B vs. G10B)
(P < 0.05). The mean rectal temperature in the uninfected group
remained below 39.5◦C throughout the monitoring period.
Fetal/lamb mortality in groups receiving 500 oocysts was
100%. In groups receiving 50 and 10 oocysts, 68% of
fetuses/lambs in G50A (in 6/6 ewes), and 66% in G10A (in
4/6 ewes) died after infection with TgShSp1, and 42% (in 2/5
ewes) of them died in both groups after infection with TgME49.
Fetal/lambmortality was increased with the oocyst doses. A lower
fetal/lamb survival rate was found in the group infected with
500 TgME49 oocysts compared with that infected 50 oocysts
(G500B vs. G50B) (P < 0.05). In addition, a significantly lower
fetal/lamb mortality was found in those infected with 500 oocysts
compared with those infected with 10 oocysts for both isolates
(G500A and G500B compared to G10A and G10B, respectively)
(P < 0.05). No differences in fetal/lamb mortality were found
between groups infected with 50 and 10 oocysts (G50A and G50B
compared to G10A and G10B, respectively). Comparing groups
that received the same dose of sporulated oocysts but different
isolates, no significant differences were found in the fetal/lamb
survival rate. Concerning fetal death during pregnancy, all ewes
challenged with 500 oocysts (G500A and G500B) aborted, and in
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TABLE 2 | Fetal/lamb mortality in sheep and percentages of placentomes/cotyledons or fetuses/lambs showing histological lesions and parasite detection.
Group Fetal/lamb
mortality (%)
Clinical
outcome
Number
of ewes
Number of
fetuses/lambs
Placentomes/cotyledons Fetal brain Fetal lung
H/E (%) PCR (%) H/E (%) PCR (%) H/E (%) PCR (%)
Group 500A (500
TgShSp1 oocysts)
100 Early abortions 5 11 NA 16 100 – – –
Late abortions 1 1 100 100 100 100 – 100
Group 500B (500
TgME49 oocysts)
100 Early abortions 5 10 NA – 100 – –
Group 50A (50
TgShSp1 oocysts)
68 Early abortions 3 7 NA 16 100 – – 14
Stillborns/lambs 3 9 NA 100 63 60 – 100
Group 50B (50 TgME49
oocysts)
42 Early abortions 1 1 NA – 100 – – –
Late abortions 1 1 100 100 100 100 – 100
Stillborns/lambs 3 5 NA 100 100 100 – 100
Group 10A (10
TgShSp1 oocysts)
66 Late abortions 1 2 100 100 100 100 – 100
Stillborns/lambs 5 13 NA 100 69 100 – 100
Group 10B (10 TgME49
oocysts)
42 Early abortions 1 2 NA – 100 – – –
Stillborns/lambs 4 5 NA 75 60 60 – 50
NA, not available.
the groups infected with lower doses, abortions were found in 3/6
and 2/5 pregnant ewes infected with 50 oocysts of TgShSp1 and
TgME49, respectively, and in 1/6 and 1/5 pregnant ewes infected
with 10 oocysts of TgShSp1 and TgME49, respectively (Table 2).
Non-aborted dams gave birth between days 143 and 149 of
pregnancy, except one ewe infected with 50 TgME49 oocysts,
which gave birth prematurely on day 134. In G50A, 1 mummified
fetus and 3 stillborn lambs were found, and in G50B, G10A,
and G10B, one, eight and one stillborn lambs were delivered,
respectively. Concerningmorbidity in lambs born alive, weakness
was found in 5 out of 5 and 1 out of 4 in groups infected with
50 oocysts, G50A and G50B, respectively, and in 2 out of 5 and
0 out of 4 in those infected with 10 oocysts, G10A and G10B,
respectively. Therefore, morbidity in lambs born alive from the
group infected with 50 TgShSp1 oocysts, G50A, was significantly
higher than the corresponding TgME49 group, G50B (P < 0.05),
whereas no significant differences in the number of weak lambs
were found between lambs from groups infected with 10 oocysts
or between lambs from groups receiving different doses of both
isolates. Dams from the pregnancy control group gave birth two
stillborn lambs and six healthy lambs between days 147 and 152
of pregnancy.
Parasite Detection and Burden in Placental and Fetal
Tissues
Placental tissues
In ewes suffering early abortions, no T. gondii DNA was detected
in placentomes in TgME49-infected animals (i.e., G500B, G50B,
and G10B), and in ewes infected with TgShSp1, parasite DNA
was only detected in one ewe infected with 500 oocysts (G500A),
which aborted on day 9 pi (one positive placentome sample
out of 30), and in one ewe infected with 50 oocysts (G50A),
which aborted on day 10 pi (one positive placentome samples
out of 18). In contrast, all placentomes from ewes showing late
abortion were PCR-positive. In ewes that delivered stillbirths or
live lambs, all cotyledons from TgShSp1-infected animals were
PCR-positive. Among those challenged with TgME49 oocysts,
100% of cotyledon samples were positive in the group infected
with 500 oocysts (G50B), while 75% of cotyledon samples were
positive in the group infected with 10 oocysts G10B (Tables 2,
S2). Concerning parasite burden (measured as the number of
tachyzoites per milligram of tissue) in cotyledons from ewes
that delivered stillbirths or live lambs, no differences were found
between groups infected with 50 and 10 oocysts in any of the
isolates. However, comparing both T. gondii isolates, parasite
loads in cotyledons from ewes that gave birth in groups infected
with 50 and 10 oocysts of TgShSp1 (groups G50A and G10A),
both were lower compared to those infected with TgME49 (G50B
and G10B) (P < 0.05) (Figure 5A).
Fetal tissues
In tissues from fetuses undergoing early abortion upon TgME49
infection, no T. gondii DNA was detected. The same was true
for fetuses from early abortions after challenge with TgShSp1
oocysts, except for one positive fetal lung sample (1 positive
sample out of 20) from one ewe that aborted on day 10 pi in one
group infected with 50 oocysts (G50A) (Tables 2, S2).
In late abortions, T. gondii DNA was detected in every fetus
and all organs analyzed (Table 2). The percentage of positive
samples in every individual organ ranged from 33% in the brain
from one fetus in G10A to 100% in the rest of the brains and lungs
from late abortions (Table S2).
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FIGURE 5 | Dot-plot graphs of T. gondii burdens in cotyledons from ewes that
gave birth (A) and brain (B) and lung (C) from stillborn lambs and live lambs
from T. gondii-infected ewes. Each dot represents individual values of parasite
burden (number of parasites per milligram of host tissue), and medians are
represented as horizontal lines. Considering that the T. gondii detection limit by
real-time PCR is 0.1 parasites, negative samples (0 parasites) were
represented on the log scale as <0.1 (i.e., 10−2). The unbroken line is used to
indicate differences between isolates, and the dashed line (———) is used to
indicate differences between doses. For significant differences between
infected groups in each tissue, *P < 0.05 and **P < 0.01.
In all stillbirths and live lambs, T. gondii DNA was found in
at least one of the studied organs, except in one stillborn lamb
and one live lamb born from one ewe infected with 10 TgME49
oocysts (G10B) in which T. gondii DNA was not detected in
any analyzed tissue (Table S2). Concerning parasite detection
in the brain of stillbirths/live lambs born from ewes infected
with TgME49 oocysts, more samples were PCR-positive in the
group infected with 50 oocysts, G50B (91.6%; 11/12; 4 out of 4
fetuses) compared to the group infected with 10 oocysts, G10B
(53.3%; 8/15; 3 out of 5 fetuses) (P < 0.05). In lambs from
ewes infected with TgShSp1 oocysts, a lower number of brain
samples were found to be PCR-positive in the group infected with
50 oocysts, G50A (33.3%; 5/15; 7 out of 9 fetuses), compared
to the group infected with 10 oocysts, G10A (66.6%; 26/39; 13
out of 13 fetuses) (P < 0.05). Similarly, lower parasite burden
in brain from lambs was found in the group infected with 50
TgShSp1 oocysts (G50A vs. G10A (P < 0.01). Comparing both
isolates, parasite detection and parasite burden were higher in
brain samples from lambs in the group infected with 50 oocysts
of TgME49 compared to the corresponding TgShSp1 group
G50B vs. G50A) (P < 0.01), while no significant differences
were found between groups infected with 10 oocysts (G10A
vs. G10B) (Figure 5B; Table 2; Table S2). In lung tissues from
stillbirths/live lambs, all samples were PCR-positive in those
groups infected with 50 oocysts (G50A and G50B). Additionally,
100% parasite detection was observed in the group infected with
10 oocysts of TgShSp1 (G10A), whereas a significantly lower
parasite detection rate was found in the group infected with
10 oocysts of TgME49, G10B (60%; 9/15; 3 out of 6 animals)
(P < 0.05). Comparison of the same oocyst dose from both
isolates revealed no differences in parasite detection in lung
samples from groups infected with 50 oocysts (G50B and G50A),
but a higher parasite detection rate was found in the group
infected with 10 TgShSp1 oocysts, G10A, compared to the group
infected with 10 TgME49 oocysts, G10B (P < 0.001) (Table 2;
Table S2). No differences in parasite burden in lungs from lambs
were found between different doses or isolates (Figure 5C).
Likewise, no differences in parasite detection or parasite burden
were found in any fetal tissue between stillborn lambs and live
lambs (data not shown). Samples from fetal tissues exhibiting
DNA degradation and mummification were excluded from PCR
analysis.
Histological Lesions and Lesion Quantification
The only evident histological lesions in the studied organs were
found in the brain from fetuses/lambs and placenta. Only the
placenta from late abortions detected through US was available
for histological study. As in those cases of early abortions,
lambing or delivery of stillbirths, it was too autolytic to allow
proper histological evaluation.
In early abortions, multifocal areas of coagulative necrosis at
the white matter (leukomalacia) were found in the brain from
all the fetuses aborted in this period. In addition, no evident
differences in the severity or number of lesions were noted
between groups. In late abortions, lesions (multifocal necrotic
placentitis) were found in all placentas studied. Likewise, there
were brain lesions (multifocal non-purulent encephalitis) in all
the fetuses from late abortions (Table 2).
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FIGURE 6 | Kinetics of the antibody production in ewes infected with TgShSp1
oocysts and the uninfected ones (A) and ewes infected with TgShSp1 oocysts
and the uninfected ones (B). From day 7 pi onwards, some ewes aborted and
were euthanized, and their data are not available. Each point represents the
mean + S.D. at the different sampling times for each group. Serum levels of
total IgG antibodies against T. gondii are expressed as a relative index percent
(RIPC), according to the formula: RIPC = (OD405 sample – OD405 negative
control)/(OD405 positive control – OD405 negative control) × 100.
In stillbirths/live lambs, glial foci with or without a central area
of necrosis were observed in the brain. These lesions were found
in lambs from all groups, with a prevalence between 60 and 100%,
depending on the group (Table 2).When the percentages of brain
lesions in lambs from ewes infected with TgME49 and TgShSp1
were compared, there were no differences between isolates or
oocyst doses tested. Furthermore, there was no difference in the
percentage of cases with brain lesions between stillbirths and
live lambs (data not shown). Lesion quantification was carried
out in brain samples from the stillbirths and live lambs, and
no significant difference was found in the number of lesions,
individual focus area or percentage of damaged area between
groups (Figure S4).
Humoral Immune Responses
The Toxoplasma-specific IgG antibody responses in dams are
shown in Figure 6. No increase in IgG level compared to
the uninfected group and no seroconversion was found in
any of the ewes showing abortion during the acute phase
of the infection. However, ewes with late abortion or those
giving birth seroconverted on day 21 pi. In the group infected
with 500 TgShSp1 oocysts, 500A, all ewes except one suffered
early abortions, so this group was excluded from statistical
analysis. From day 21 pi onwards, ewes infected with 50 and
10 oocysts seroconverted and exhibited higher IgG compared
to the control group (P < 0.05). When analyzing the IgG
levels of animals infected with TgShSp1 sporulated oocysts, no
significant differences were found between ewes infected with
50 and 10 oocysts, G50A and G10A (Figure 6A). However,
in animals infected with TgME49 sporulated oocysts, it is
noteworthy that the group infected with 10 oocysts, G10B,
had higher IgG on day 21 pi than the group infected with
50 oocysts, G50B (P < 0.01) (Figure 6B). Comparing groups
receiving the same dose of sporulated oocysts, no significant
differences in IgG level were found between groups infected
with 50 oocysts, G50A and G50B. However, the group infected
with 10 oocysts of TgShSp1, G10A, displayed lower IgG than
that infected with TgME49, G10B, from day days 21 to 35 pi
(P < 0.01). All uninfected control animals exhibited basal IgG
levels within the reference range throughout the experimental
study.
None of the fetuses that were aborted before day 11 pi had
detectable IgG against T. gondii antigen. In contrast, fetuses
undergoing late abortions were IgG-positive. Of the lambs born
from TgShSp1-infected ewes, seven out of eight and nine out
of twelve lambs were positive in groups infected with 50 and
10 TgShSp1 oocysts, G50A and G10A, respectively. Similarly, of
the lambs born from TgME49-infected ewes, two out of three
and 50% of lambs born from those groups infected with 50 and
10 TgME49 oocysts, G50B and G10B, respectively, were positive
(Table S3). Specific IgG responses against parasite antigen were
not detected in lambs from the uninfected group.
Comparative Assessment of Congenital
Infection in Mice and Sheep After Infection
With TgShSp1 Oocysts
Offspring mortality after infection with 500 TgShSp1 oocysts
occurred in sheep at a statistically higher rate compared
to mice (P < 0.001), since in sheep all fetuses died and
in mice only 50% of the pups died. Similarly, higher
offspring mortality was found in sheep compared to mice after
infections with intermediate (P < 0.0001) and low doses of
oocysts (P < 0.01), since infection with 50 and 10 TgShSp1
oocysts triggered mortality in 68 and 66% of fetuses/lambs,
whereas in mice mortality of 9 and 27% of the pups was
observed after infection with 100 and 25 TgShSp1 oocysts,
respectively.
Since no lambs were born in the group infected with 500
TgShSp1 oocysts, offspring morbidity in this group could not be
assessed. However, in mice infected with 500 TgShSp1 oocysts, a
decrease in pup body weight was found from day 14 pi onwards.
Offspring from mice infected with 100 TgShSp1 oocysts showed
a decrease in bodyweight from day 14 pi onwards, and all
lambs born alive from ewes infected with 50 TgShSp1 exhibited
weakness at birth. At low doses of oocysts, no body weight
decrease was noted in pups born from mice infected with 25
TgShSp1 oocysts; however, 2 out 5 live lambs from ewes infected
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with 10 TgShSp1 oocysts were born with obvious weakness and
impaired health.
All (100%) of the surviving mouse pups were PCR-positive
in the brain, and 100% live lambs were seropositive or with a
PCR-positive result in at least one tissue after infection with
intermediate doses of oocysts (100 TgShSp1 oocysts in mice
and 50 TgShSp1 oocysts in sheep). Additionally, 100% of the
surviving pups were PCR-positive in the brain after infection
with 500 TgShSp1 oocysts (high dose of oocysts). However, a
statistically higher number of T. gondii-positive offspring were
found in sheep compared to mice after infection with low doses
of oocysts (P < 0.05), since 100% lambs were seropositive or with
a PCR-positive result in at least one tissue after infection with
10 TgShSp1 oocysts and only 37% of the surviving pups were
PCR-positive in the brain after infection with 25 TgShSp1 oocysts
(Table 3).
DISCUSSION
Toxoplasma gondii is an apicomplexan parasite that is distributed
worldwide (Dubey, 2010). In Europe and North America,
T. gondii isolates display a clonal population structure, with
the vast majority of T. gondii isolates being grouped into three
lineages, namely, types I, II and III (Howe and Sibley, 1995). Type
II T. gondii is the most prevalent in all hosts in Europe, including
sheep (Dumètre et al., 2006; Halos et al., 2010; Su et al., 2010).
Previous studies in Europe have shown that T. gondii type II is
associated with ovine abortion (Owen and Trees, 1999; Jungersen
et al., 2002; Chessa et al., 2014). In Spain, type II is the most
prevalent genotype in wild animals and cats (Montoya et al., 2008;
Calero-Bernal et al., 2015), as well as in previously obtained ovine
isolates (Fuentes, 1999). The TgShSp1 isolate belongs to genotype
#3 (a type II variant, type II for nine alleles/type I for Apico),
sharing genotype with the Prugniaud (PRU) isolate.
Toxoplasma gondii PRU isolates exhibit a similar genetic
pattern to the T. gondii type II reference isolate, TgME49
(genotype #1, type II for the studied alleles) (Su et al., 2012).
In addition, both type II isolates, TgME49, and PRU, activate
the host cell transcription factor NF-κB, an integral component
of the immune response to T. gondii, and they display identical
GRA15 gene sequences, which is involved in NF-κB activation
(Rosowski et al., 2011). TgME49 was isolated from sheep muscle
in 1958 (Lunde and Jacobs, 1983) and has since then undergone
long-term passaging in cell culture and mice (Sibley et al.,
2002). Previous studies have demonstrated changes in biological
characteristics of T. gondii isolates after passages in mice and
cell culture (Frenkel et al., 1976; Lindsay et al., 1991; Harmer
et al., 1996; Saraf et al., 2017). This fact has been widely
studied in T. gondii type I isolates (Cesbron and Sabin, 1994;
Villard et al., 1997; Dubey et al., 1999; Mavin et al., 2004; Khan
et al., 2009). However, whether these changes also occur in
type II isolates, and how they compare to recently obtained
isolates, remains unknown. Increased growth in vitro can be
found after repeated passages (Yano et al., 1987). The dramatic
differences observed during in vitro growth of TgME49 and
TgShSp1 might reflect the highly different passage history of the
two isolates. Plaque formation is commonly used to measure
growth of T. gondii, and this process is the result of several
events, including invasion, growth, egress, and migration (Roos
et al., 1994). Notably, TgME49 tachyzoites formed plaques at
4 days pi, but TgShSp1 did not. The finding that TgShSp1 did
not form plaques in vitro could have resulted from the limited
growth rate, associated with a higher capacity of bradyzoite
conversion, as previously described (Khan et al., 2009). This
was confirmed by monitoring spontaneous cyst formation
through labeling with the fluorescent lectin DBL, demonstrating
tissue cyst formation under standard cell culture procedures
in TgShSp1 that was greater than TgME49. Due to its high
passage number in cell culture or mice, our TgME49 isolate
may not accurately represent natural virulence traits of the
type II lineage, which suggests that comparisons of phenotypes
between T. gondii isolates should be conducted using low-passage
stocks.
Traditionally, mouse models are utilized to evaluate virulence
by monitoring survival after experimental infection. Type I
isolates are highly virulent in mice (LD100 of 1 tachyzoite),
whereas types II and III exhibit median lethal doses (LD50)
that range from 102 to 105 (Saeij et al., 2006). Conventionally,
TgME49 is a cystogenic type II isolate with low virulence in
mice (Ferreira et al., 2001; Gavrilescu and Denkers, 2001; Oliveira
et al., 2016). Intraperitoneal inoculation of 103 and 5 × 104
TgME49 tachyzoites intraperitoneally has not caused mortality
(Ferreira et al., 2001; Oliveira et al., 2016). However, in this
study, TgME49 displayed a LD50 of 103, so the virulence of our
TgME49 could be considered stronger than previous descriptions
(Ferreira et al., 2001; Oliveira et al., 2016). Enhanced virulence
in mice for T. gondii strains maintained for several passages
has also been reported previously (Shimizu et al., 1967; Sibley
and Boothroyd, 1992; Frenkel and Ambroise-Thomas, 1996).
Hence, it seems logical to speculate that results from studies
using laboratory isolates should be validated with more recent
isolates before they can be extrapolated as general features of
the respective lineage. In contrast to TgME49, mice inoculated
with tachyzoites of the recently obtained type II isolate TgShSp1
exhibited only moderate, low-level clinical signs, but nomortality
(LD50 > 105), similar to what was described earlier after
intraperitoneal inoculation of Swiss Webster mice with 103
tachyzoites of a PRU isolate (Wang et al., 2013). In addition,
although oocysts are considered more virulent than tachyzoites
in mice (Dubey and Frenkel, 1973), no mortality in adult
mice was found after infection with oocysts of TgShSp1 in
pregnant and non-pregnant mice, suggesting very low virulence
in mice.
In the present work, we also investigated congenital
toxoplasmosis in pregnant mice by inoculating them orally
with different doses of TgShSp1 oocysts. The risk of congenital
toxoplasmosis depends on the virulence of the parasite (Tenter
et al., 2000). Based on the previously established toxoplasmosis
model using TgME49 oocysts (Müller et al., 2017), we infected
mice at day 7 post-mating, which represents the beginning of
the second term of gestation. Few mice infected with TgShSp1
oocysts showed mild clinical signs, contrary to the large number
of mice succumbing to infection after the same oocyst doses of
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TABLE 3 | Summary of the outcome of the congenital infection in mice and sheep after infection with different doses of TgShSp1 oocysts.
Doses of oocysts (Mice/Sheep) Offspring mortalitya
(Mice/Sheep)
Morbidity in the offspringb
(Mice/Sheep)
Vertical transmissionc
(Mice/Sheep)
High (500 oocysts/500 oocysts) Medium/High*** High/NA High/NA
Intermediate (100 oocysts/50 oocysts) Low/High**** High/High High/High
Low (25 oocysts/10 oocysts) Low/Medium** –/Medium Medium/High*
aMortality of fetuses during pregnancy in sheep and of pups/lambs after birth in mice and sheep.
bMorbidity in the offspring was evaluated by decrease of the body weight of pups from day 14 pp in mice and by clinical signs in live lambs (weakness) at birth.
c In mice, PCR-positive brains in surviving pups at day 28 pp. In sheep, seropositive live lambs with a PCR-positive result in at least one tissue.
NA, not available. High, medium, low or minus (–) mean presence of clinical signs, offspring mortality, or vertical transmission of the parasite in >67, 66–34, <33, and 0% of the
fetuses/pups/lambs, respectively. Body weights lower than the uninfected group are considered high morbidity, while no difference compared to uninfected group is represented as
minus (–). *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 significant differences between mice and sheep in the number of fetuses/pups/lambs died or in the number of
surviving offspring infected with T. gondii.
TgME49 (Müller et al., 2017). There is a possibility that there
has been a selection toward increased virulence within TgME49
due to the successive passages, as explained above but also due
to the sulfadimidine treatment that was applied in mice used for
infection of cats to generate TgME49 oocysts used in this study
(Müller et al., 2017). This sulfonamide treatment could act as a
bottleneck in selecting tachyzoites with a faster replication and
therefore increasing the virulence in mice of the final TgME49
parasites. Unlike what was observed for TgME49 (Müller et al.,
2017), with which a clear effect on pregnancy rate was found
after infection with 2,000 oocysts and on litter size after infection
with 500 oocysts, infection with TgShSp1 oocysts did not result
in alteration of pregnancy rate or litter size. Likewise, while 92%
of the pups died after infection of dams with 25 TgME49 oocysts
(Müller et al., 2017), a significant decrease in pup survival was
found only after infection with 2,000 and 500 TgShSp1 oocysts,
where there was mortality in 50% of the pups. In conclusion,
infection of mice with TgShSp1 oocysts at mid-pregnancy did not
generate severe clinical signs in adult mice, but infection doses
of 2,000 and 500 oocysts in the dams resulted in mortality of
50% of the pups and decreased body weight in surviving pups,
and 100% vertical transmission occurred with doses of up to 100
oocysts.
Sheep are a relevant host of the parasite and could suffer
abortions when primo infected during gestation (Vargas-
Villavicencio et al., 2016). Fetal/lamb mortality was similar
for both isolates. However, those ewes infected with 10 and
50 TgME49 oocysts and that delivered stillbirths/live lambs
exhibited higher parasite load in cotyledons than those infected
with the same doses of TgShSp1 oocysts. Similarly, a higher
parasite load was found in the brain from lambs born in the group
infected with 50 TgME49 oocysts compared to the corresponding
TgShSp1 group. Therefore, it is tempting to hypothesize that
the enhanced virulence of our TgME49 contributed to the
abovementioned effects. Comparing different doses of infection,
there is a correlation between the dose of infection and the
rate of early abortions, as previously suggested (Mévélec et al.,
2010; Benavides et al., 2017). Infection with 500 oocysts triggered
abortion in all fetuses, similar to previous experimental infections
in pregnant sheep at mid-pregnancy using 2,000 oocysts of M1
and M4 isolates (Owen et al., 1998; Castaño et al., 2014). After
infection with 50 TgShSp1 oocysts or 50 TgME49 oocysts, 68
and 42% of fetuses/lambs died, respectively, similar to what
was previously reported after infection with 50 M4 oocysts
(Castaño et al., 2014). The occurrence of abortions after infection
with 10 oocysts was low, but large numbers of stillbirths and
weak lambs were found, mainly in the 10 TgShSp1 oocysts
group. There seems to be a correlation between the presence
of the parasite and the occurrence of stillbirths, since stillbirths
from the group infected with 10 TgShSp1 oocysts exhibited
higher parasite detection and load in the brain than those in
the group infected with 50 TgShSp1 oocysts. Regardless of the
isolate or dose, no differences were found in the congenital
infection of lambs born, since vertical transmission was found
in all them except in one stillborn lamb and one live lamb
born from one ewe infected with 10 TgME49 oocysts. Likewise,
no differences were found between doses or isolates with
respect to brain lesion presence and lesion severity in lambs
born.
Most of the experimental studies in pregnant sheep carried
out so far used M1, M3, and M4 T. gondii type II isolates
for infection (Dubey, 2009; Castaño et al., 2014). However,
although numerous experimental infections were also carried
out in mice with these isolates (Nicoll et al., 1997; Owen et al.,
1998; Hamilton et al., 2018), their virulence in mice models has
not been studied in depth. Therefore, the correlation between
virulence in mice and outcome of experimental infections in
pregnant sheep has not been elucidated. Despite the clear
differences in body weight between mice and sheep, in the
current study, similar doses of oocysts were used to compare
both hosts. None of the adult mice challenged with 25 TgShSp1
oocysts exhibited clinical signs, whereas all ewes challenged with
10 TgShSp1 oocysts had fever. Therefore, morbidity in sheep
seems to be higher than in mice. In addition, no mortality was
observed in adult mice or sheep infected with TgShSp1 oocysts.
When comparing the congenital infection after challenge at mid-
pregnancy between both hosts, 50% mortality was caused in
mice by infection with 500 TgShSp1 oocysts, whereas in sheep
infection with the same oocyst dose caused mortality in all
fetuses. In brief, mice seem to be less susceptible to offspring
mortality than sheep, despite the fact that vertical transmission
was similar in both species. High vertical transmission and low
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 14 January 2019 | Volume 8 | Article 436
Sánchez-Sánchez et al. Comparative Virulence Assessment of T. gondii
offspring mortality could be an evolutionary strategy of the
parasite to generate a large infected offspring group in mice, one
of the most relevant hosts of T. gondii (Müller and Howard,
2016).
There are several differences between mice and sheep
that could underlie the differences found in this study. The
histological structure of the placenta is very different between
mice and sheep (Entrican, 2002), and although maternal blood
and fetal tissue are closer in mice, allowing an easy crossing of
tachyzoites but also of antibodies, the longer period of gestation,
the lack of maternal antibodies crossing the placental barrier
and fewer fetuses may facilitate vertical transmission in sheep.
In addition, host genetics are likely important in determining
susceptibility and severity of infection (Howe et al., 1996; Müller
and Howard, 2016). Small rodents, natural intermediate hosts,
are often exposed to a higher dose and more virulent parasites
than other groups of mammals. It may therefore be that Toll-
Like-Receptors (TLR)11 and TLR12 and the polymorphism of
immunity-related GTPases (IRG proteins) have been positively
selected in rodents, because of their critical importance in host
resistance against high infection loads or more virulent clones
of T. gondii. In mice, TLR11 and TLR12 on dendritic cells
detect the apicomplexan actin-binding protein profilin leading to
the secretion of interleukin 12 (IL12), which can subsequently
induce production of IFNγ by T cells. IFNγ induces a variety
of parasiticidal mechanisms, which in mice are dominated by
upregulation of the IRGs (Gazzinelli et al., 2014). IRGs can
destroy the vacuole in these parasites live and subsequently the
parasite itself. Considering the ubiquity of T. gondii in nature,
it is intriguing that genes encoding TLR11, TLR12, and IRG
proteins are not found in many mammalian species (Gazzinelli
et al., 2014). Although further studies are needed, and despite
the influence of genetic polymorphisms in ovine abortions
(Darlay et al., 2011), this fact could render sheep less resistant.
Similarly, differences in immune cell populations may influence
the pathogenesis of toxoplasmosis in these hosts. γδT cells, which
rapidly recognize and respond to non-processed antigens and
seem to have an important role in T. gondii infection (Egan
et al., 2005), represent a relevant subset of circulating T cells in
sheep compared to mice (Holderness et al., 2013). Further studies
are needed to characterize the cellular and molecular bases
contributing to transmission dynamics and disease in different
hosts of T. gondii (Dubremetz and Lebrun, 2012; Hunter and
Sibley, 2012).
In conclusion, we have demonstrated that infection with
tachyzoites and oocysts of the type II T. gondii isolate TgShSp1
in mice does not cause mortality, but this isolate is efficiently
vertically transmitted in pregnant mice, and compared to sheep,
it triggers lower offspring mortality and morbidity. Thus, at
least for this isolate, the disease caused in pregnant mice and
offspring is not a reliable predictor/indicator for disease caused in
pregnant sheep at mid-gestation. Whether this conclusion is also
valid for other type II T. gondii strains needs to be addressed in
future studies. In addition, our results suggest that the laboratory
isolate TgME49 exhibits an enhanced virulence due to successive
passages in cell culture and mice. Thus, virulence traits may
have been modified, and it might be advisable to use low-passage
isolates in experimental studies, as these probably provide a more
realistic picture of the true nature of the parasite biology in the
field.
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Figure S1 | Box-plots showing IgG serum titers generated in dams (A) and
non-pregnant mice (B) infected with TgShSp1 oocysts and the uninfected group.
Graphs represent the median percentage, the lower and upper quartiles (boxes)
and minimum and maximum values (whiskers). For significant differences in serum
titres, ∗P < 0.05 and ∗∗P < 0.01.
Figure S2 | Dot-plot graphs of T. gondii burdens in brain from dams (A) and
non-pregnant mice (B). Each dot represents individual values of parasite burden
(number of parasites per microgram of DNA), and medians are represented as
horizontal lines.
Figure S3 | Dot-plot graphs of T. gondii burdens in lung from dams (A) and
non-pregnant mice (B). Each dot represents individual values of parasite burden
(number of parasites per microgram of DNA), and medians are represented as
horizontal lines.
Figure S4 | Dot-plots showing number of lesions (A), individual focus area (B),
and percentage of damaged area (C) in the brains from stillborn lambs and live
lambs. Each dot represents individual, and medians are represented as horizontal
lines.
Table S1 | Clinical signs, serological titers, and parasite detection in mice
intraperitoneally infected with TgME49 and TgShSp1 tachyzoites.
Table S2 | Individual frequency of parasite DNA detection in infected animals.
Table S3 | Individual serological titers in fetuses/lambs from infected ewes.
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